News: Zonisamide

An epilepsy drug used to treat partial seizures in adults can cause excessive acidity of the blood in some patients, says the FDA.Zonisamide is sold by a number of generic drugmakers as well as under the brand Zonegran by Eisai Co Ltd.

Zonisamide, a generic epilepsy drug, could cause metabolic acidoses, the FDA warns.

Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, announced the initiation of its first clinical trial with OREX-003, a proprietary sustained release formulation of zonisamide plus olanzapine. The Phase 2a clinical trial, OZ-101, is desi

NEW YORK (Reuters Health) - The anti-seizure drug zonisamide, which goes by the brand name Zonegran, is effective short-term treatment for binge-eating disorder associated with obesity, according to the results of a small study. However, the treatment is not well tolerated.

Zonisamide, a drug used to treat epilepsy, has been found to significantly improve tremors, motor fluctuations, and other involuntary movements, or dyskinesias, in patients with Parkinson disease.